X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3026) 3026
Publication (271) 271
Book Review (47) 47
Book Chapter (37) 37
Book / eBook (5) 5
Conference Proceeding (3) 3
Dissertation (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2289) 2289
index medicus (1878) 1878
female (1370) 1370
male (1346) 1346
middle aged (1172) 1172
aged (952) 952
adult (834) 834
surgery (729) 729
treatment outcome (578) 578
risk factors (567) 567
oncology (522) 522
neoplasm, residual (502) 502
retrospective studies (453) 453
cancer (432) 432
prognosis (426) 426
urology & nephrology (423) 423
medicine & public health (407) 407
mortality (371) 371
analysis (363) 363
cardiac & cardiovascular systems (358) 358
aged, 80 and over (354) 354
survival (351) 351
care and treatment (323) 323
time factors (315) 315
residual renal-function (287) 287
follow-up studies (267) 267
research (259) 259
minimal residual disease (252) 252
neoplasm staging (244) 244
chemotherapy (243) 243
health aspects (240) 240
hematology (234) 234
prospective studies (234) 234
adolescent (221) 221
survival rate (219) 219
peritoneal dialysis (210) 210
young adult (209) 209
animals (208) 208
recurrence (198) 198
risk (194) 194
tumors (194) 194
peripheral vascular disease (188) 188
management (185) 185
kidney failure, chronic - therapy (181) 181
disease-free survival (177) 177
respiratory system (175) 175
hemodialysis (172) 172
carcinoma (171) 171
risk assessment (165) 165
multivariate analysis (156) 156
neoplasm, residual - pathology (156) 156
residual risk (156) 156
diagnosis (155) 155
patients (155) 155
therapy (155) 155
child (151) 151
abridged index medicus (144) 144
proportional hazards models (144) 144
radiology, nuclear medicine & medical imaging (142) 142
residual renal function (140) 140
metastasis (139) 139
kaplan-meier estimate (138) 138
disease (137) 137
lymphatic metastasis (136) 136
inflammation (134) 134
medical research (133) 133
survival analysis (133) 133
outcomes (130) 130
predictive value of tests (128) 128
neoplasm invasiveness (125) 125
usage (122) 122
article (120) 120
cardiovascular disease (119) 119
pediatrics (119) 119
functional residual capacity (118) 118
radiotherapy (116) 116
combined modality therapy (115) 115
clinical neurology (111) 111
resection (111) 111
breast cancer (110) 110
nephrology (110) 110
gastroenterology & hepatology (108) 108
medicine (108) 108
medicine, experimental (108) 108
patient outcomes (107) 107
cohort studies (106) 106
follow-up (106) 106
hematology, oncology and palliative medicine (105) 105
studies (105) 105
magnetic resonance imaging (103) 103
cardiovascular-disease (102) 102
breast neoplasms - pathology (100) 100
cardiovascular diseases (100) 100
neoplasm recurrence, local (99) 99
antineoplastic combined chemotherapy protocols - therapeutic use (98) 98
neoplasm recurrence, local - pathology (98) 98
diabetes (96) 96
medical colleges (96) 96
risk-factors (96) 96
children (95) 95
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2980) 2980
Spanish (35) 35
German (22) 22
Russian (7) 7
French (6) 6
Czech (3) 3
Italian (3) 3
Hungarian (2) 2
Polish (2) 2
Serbian (2) 2
Japanese (1) 1
Portuguese (1) 1
Slovak (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


DIABETES & VASCULAR DISEASE RESEARCH, ISSN 1479-1641, 11/2008, Volume 5, Issue 4, pp. 319 - 335
Journal Article
Diabetes & Vascular Disease Research, ISSN 1479-1641, 11/2008, Volume 5, Issue 4, pp. 319 - 335
Despite current standards of care aimed at achieving targets for low-density lipoprotein (LDL) cholesterol, blood pressure and glycaemia, dyslipidaemic... 
Pharmacotherapy | Lifestyle | Microvascular | Residual risk | Macrovascular
Journal Article
Atherosclerosis, ISSN 0021-9150, 11/2019, Volume 290, pp. 59 - 65
In patients with cardiovascular disease, considerable residual risk remains despite evidence-based secondary prevention measures. Alkaline phosphatase (ALP)... 
Alkaline phosphatase | Residual cardiovascular risk | Epigenetic | Major adverse cardiovascular event | apabetalone
Journal Article
Pharmacogenetics and Genomics, ISSN 1744-6872, 12/2007, Volume 17, Issue 12, pp. 1057 - 1064
Journal Article
JOURNAL OF HYPERTENSION, ISSN 0263-6352, 12/2014, Volume 32, Issue 12, pp. 2305 - 2314
Background: Randomized controlled trials (RCTs) of blood pressure (BP) lowering lend themselves to be meta-analyzed to help providing evidence-based... 
residual risk | DISEASE | meta-analysis | PREVENTION | PERIPHERAL VASCULAR DISEASE | blood-pressure-lowering treatment | cardiovascular risk | randomized controlled trials | hypertension | ANTIHYPERTENSIVE TREATMENT
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 08/2018, Volume 104, Issue 2, pp. 244 - 256
Cardiovascular diseases (CVD) are the first cause of death in the world. CVD risk is influenced by multiple factors, some nonmodifiable such as age, sex, and... 
C-REACTIVE PROTEIN | ALL-CAUSE MORTALITY | DENSITY-LIPOPROTEIN CHOLESTEROL | INTENSIVE STATIN THERAPY | NON-HDL CHOLESTEROL | RESIDUAL VASCULAR RISK | TRIAL EVALUATING ROSUVASTATIN | PHARMACOLOGY & PHARMACY | OF-FUNCTION MUTATIONS | VERY-LOW LEVELS | CORONARY-HEART-DISEASE
Journal Article